Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Interventions in Obesity & Diabetes

Hypoglycemic Episodes Due to Synergistic Effect of Drugs in a Woman with Diabetes and Rheumatoid Arthritis

  • Open or CloseArgyrios V Tsakalis*

    Internal Medicine Outpatient Clinic, Health Center of Kastoria, Greek National Health System, Aristotle University of Thessaloniki, Greece

    *Corresponding author:Argyrios V Tsakalis, Internal Medicine Outpatient Clinic, Health Center of Kastoria, Greek National Health System, Aristotle University of Thessaloniki, Greece

Submission: April 24, 2020Published: May 15, 2020

DOI: 10.31031/IOD.2020.04.000580

ISSN : 2578-0263
Volume4 Issue1

Abstract

Hydroxychloroquine (HCQ) and Leflunomide (LE) are agents that are commonly used to treat rheumatoid arthritis. Type 2 Diabetes (DM2) patients are in increased risk of hypoglycemia. The present report documents a case of repeated dawn hypoglycemic episodes due to concomitant use of HCQ, LE and Repaglinide in a patient with Rheumatoid arthritis and DM2

Keywords:Hydroxychloroquine, Leflunomide, Repaglinide, Hypoglycemia, Type 2 Diabetes, Rheumatoid arthritis

  • Abbreviations: HCQ: Hydroxy Chloro Quine; LEF: Leflunomide; DM2: Type 2 Diabetes; RA: Rheumatoid Arthritis; RE: Repaglinide; HYPO: Hypoglycemia; SITA: Sitagliptin

  • Get access to the full text of this article